The deubiquitinase USP21 stabilizes MEK2 to promote tumor growth

作者: Wenjuan Li , Kaisa Cui , Edward V Prochownik , Youjun Li

DOI: 10.1038/S41419-018-0523-Z

关键词:

摘要: Deubiquitinases (DUBs) play essential roles in normal cell proliferation and tumor growth. However, the molecular mechanisms of DUBs on hepatocellular carcinoma (HCC) remains largely unknown. In this study, based analysis several HCC datasets, we found that USP21 gene, which encodes a member ubiquitin-specific protease family, is highly amplified overexpressed HCCs, with extent up-regulation significantly correlating poor clinical outcomes. Inhibition lines decreased proliferation, anchorage-independent growth, cycle progression, vivo Conversely, ectopic expression transformed human hepatocyte line HL-7702 increased tumorigenicity MHCC97L. Mechanistically, stabilized MEK2 by decreasing its polyubiquitination at Lys48, thereby activating ERK signaling pathway. Importantly, partially mediated optimal USP21-mediated oncogenic phenotypes. These findings indicate deubiquitination stabilization critical role development.

参考文章(46)
Anand Mehta, Harmin Herrera, Timothy Block, Glycosylation and liver cancer. Advances in Cancer Research. ,vol. 126, pp. 257- 279 ,(2015) , 10.1016/BS.ACR.2014.11.005
Chao-Feng Zheng, Kun-Liang Guan, None, Cloning and characterization of two distinct human extracellular signal-regulated kinase activator kinases, MEK1 and MEK2. Journal of Biological Chemistry. ,vol. 268, pp. 11435- 11439 ,(1993) , 10.1016/S0021-9258(18)82142-1
William B. Coleman, Mechanisms of human hepatocarcinogenesis. Current Molecular Medicine. ,vol. 3, pp. 573- 588 ,(2003) , 10.2174/1566524033479546
A Tannapfel, F Sommerer, M Benicke, A Katalinic, D Uhlmann, H Witzigmann, J Hauss, C Wittekind, Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma Gut. ,vol. 52, pp. 706- 712 ,(2003) , 10.1136/GUT.52.5.706
Kostas Nikolaou, Ageliki Tsagaratou, Christina Eftychi, George Kollias, George Mosialos, Iannis Talianidis, Inactivation of the Deubiquitinase CYLD in Hepatocytes Causes Apoptosis, Inflammation, Fibrosis, and Cancer Cancer Cell. ,vol. 21, pp. 738- 750 ,(2012) , 10.1016/J.CCR.2012.04.026
Bénédicte Delire, Peter Stärkel, The Ras/MAPK pathway and hepatocarcinoma: pathogenesis and therapeutic implications European Journal of Clinical Investigation. ,vol. 45, pp. 609- 623 ,(2015) , 10.1111/ECI.12441
Joshua T. Mendell, Eric N. Olson, MicroRNAs in Stress Signaling and Human Disease Cell. ,vol. 148, pp. 1172- 1187 ,(2012) , 10.1016/J.CELL.2012.02.005
T. Nakagawa, T. Kajitani, S. Togo, N. Masuko, H. Ohdan, Y. Hishikawa, T. Koji, T. Matsuyama, T. Ikura, M. Muramatsu, T. Ito, Deubiquitylation of histone H2A activates transcriptional initiation via trans-histone cross-talk with H3K4 di- and trimethylation Genes & Development. ,vol. 22, pp. 37- 49 ,(2008) , 10.1101/GAD.1609708
S Whittaker, R Marais, A X Zhu, The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene. ,vol. 29, pp. 4989- 5005 ,(2010) , 10.1038/ONC.2010.236
Youjun Li, Fengfeng L. Xu, Jie Lu, William S. Saunders, Edward V. Prochownik, Widespread Genomic Instability Mediated by a Pathway Involving Glycoprotein Ibα and Aurora B Kinase Journal of Biological Chemistry. ,vol. 285, pp. 13183- 13192 ,(2010) , 10.1074/JBC.M109.084913